| Literature DB >> 12778065 |
D Feskanich1, W C Willett, D J Hunter, G A Colditz.
Abstract
Within the two Nurses' Health Study cohorts of US women, we examined whether higher intakes of vitamin C, vitamin E, retinol, or individual tocopherols or carotenoids are associated with a lower risk of melanoma. We confirmed 414 cases of invasive melanoma among over 162,000 Caucasian women aged 25-77 years during more than 1.6 million person-years of follow-up. Diet was measured every 4 years with a food frequency questionnaire and supplement use was reported every 2 years. Several measures of sun sensitivity were assessed and included in proportional hazards models. We found that vitamins A, C, E and their individual components were not associated with a lower risk of melanoma. Only retinol intake from foods plus supplements appeared protective within a subgroup of women who were otherwise at low risk based on nondietary factors (relative risk (RR)=0.39, 95% confidence interval (CI) 0.22-0.71 for >/=1,800 vs 400 microg day(-1), P for linear trend=0.01). Contrary to expectation, we observed higher risks of melanoma with greater intakes of vitamin C from food only (RR=1.43, 95% CI 1.01-2.00 for >/=175 vs <90 mg day(-1), P for linear trend=0.05) and a significant positive dose-response with frequency of orange juice consumption (P=0.008). Further research is needed to determine whether another component in foods such as orange juice may contribute to an increase in risk.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12778065 PMCID: PMC2741035 DOI: 10.1038/sj.bjc.6600882
Source DB: PubMed Journal: Br J Cancer ISSN: 0007-0920 Impact factor: 7.640
Age-standardised characteristicsa within the low and high categories of vitamin C, vitamin E, retinol, and β-carotene intakes from foods plus supplements among the women in the NHS (n=73 432) and NHS II (n=88 541) study populations
| Median daily intake | 86 | 694 | 8 | 187 | 285 | 2469 | 1907 | 7455 |
| Age (years) | 54 | 58 | 55 | 58 | 54 | 56 | 54 | 58 |
| Postmenopausal (%) | 57 | 73 | 62 | 76 | 59 | 73 | 57 | 77 |
| Postmenopausal hormone user | 27 | 41 | 26 | 43 | 28 | 38 | 30 | 37 |
| Nulliparous (%) | 6 | 8 | 6 | 7 | 6 | 7 | 6 | 7 |
| Body mass index (kg m−2) | 25.7 | 25.1 | 25.6 | 25.1 | 25.4 | 25.2 | 25.6 | 25.2 |
| Height (cm) | 164 | 164 | 164 | 164 | 164 | 164 | ′164 | 164 |
| Painful burn or blisters during | ||||||||
| childhood after 2 h in sun (%) | 15 | 15 | 14 | 15 | 15 | 15 | 15 | 15 |
| 6+ sunburns in lifetime (%) | 55 | 58 | 53 | 59 | 56 | 57 | 57 | 55 |
| 3+ moles on left arm (%) | 12 | 13 | 12 | 13 | 12 | 12 | 12 | 12 |
| Red or blonde hair (%) | 15 | 16 | 15 | 16 | 15 | 17 | 15 | 16 |
| Parent or sibling with melanoma (%) | 3 | 4 | 3 | 4 | 3 | 4 | 4 | 4 |
| Median daily intake | 85 | 690 | 8 | 187 | 296 | 2375 | 1763 | 7721 |
| Age (years) | 39 | 41 | 39 | 42 | 40 | 39 | 40 | 42 |
| Premenopausal (%) | 88 | 86 | 89 | 84 | 87 | 88 | 89 | 87 |
| Oral contraceptive user | 10 | 10 | 10 | 10 | 10 | 9 | 10 | 9 |
| Nulliparous (%) | 20 | 33 | 21 | 31 | 23 | 25 | 21 | 27 |
| Body mass index (kg m−2) | 26.0 | 24.9 | 25.4 | 24.7 | 25.6 | 25.0 | 25.9 | 25.2 |
| Height (cm) | 164 | 164 | 164 | 164 | 165 | 165 | 165 | 165 |
| Painful burn or blisters during | ||||||||
| childhood after 2 h in sun (%) | 25 | 25 | 24 | 25 | 24 | 25 | 25 | 25 |
| 3+ sunburns in teen years (%) | 28 | 28 | 26 | 27 | 28 | 27 | 27 | 28 |
| 5+ moles on lower legs (%) | 21 | 22 | 21 | 23 | 21 | 22 | 22 | 21 |
| Red or blonde hair (%) | 19 | 22 | 20 | 22 | 19 | 22 | 20 | 21 |
| Parent or sibling with melanoma (%) | 5 | 6 | 5 | 6 | 5 | 5 | 5 | 5 |
Values are means or percentages of the population within categories of nutrient intakes and are standardised to the age distribution of the study populations over follow-up (NHS 1984–1998; NHS II 1991–1999).
mg of α-tocopherol equivalents.
Percent postmenopausal hormone users is calculated among postmenopausal women only.
Percent oral contraceptive users is calculated among premenopausal women only.
Relative risks (RRs) of melanoma by daily intakes of vitamin C, vitamin E, retinol, and β-carotenea
| Total | ||||
| <110 | 60 | 315 | 1.00 | 1.00 |
| 110–159 | 89 | 363 | 1.26 (0.73–2.19) | 1.21 (0.71–2.06) |
| 160–219 | 78 | 312 | 1.31 (0.93–1.84) | 1.21 (0.86–1.71) |
| 220–399 | 81 | 323 | 1.31 (0.93–1.85) | 1.19 (0.84–2.68) |
| ⩾400 | 106 | 335 | 1.50 (0.78–2.89) | 1.33 (0.74–2.38) |
| 0.27 | 0.53 | |||
| Dietary | ||||
| <90 | 57 | 325 | 1.00 | 1.00 |
| 90–114 | 73 | 307 | 1.32 (0.93–1.87) | 1.27 (0.90–1.80) |
| 115–139 | 74 | 322 | 1.29 (0.91–1.82) | 1.24 (0.87–1.76) |
| 140–174 | 112 | 353 | 1.72 (1.24–2.37) | 1.62 (1.17–2.25) |
| ⩾175 | 98 | 341 | 1.51 (1.08–2.11) | 1.43 (1.02–2.00) |
| 0.04 | 0.05 | |||
| Total | ||||
| <9.0 | 72 | 343 | 1.00 | 1.00 |
| 9.0–10.9 | 85 | 317 | 1.25 (0.77–2.04) | 1.19 (0.75–1.90) |
| 11.0–16.9 | 77 | 318 | 1.15 (0.83–1.59) | 1.05 (0.76–1.45) |
| 17.0–49.9 | 89 | 357 | 1.18 (0.68–2.07) | 1.09 (0.64–1.83) |
| ⩾50.0 | 91 | 313 | 1.25 (0.70–2.23) | 1.11 (0.66–1.85) |
| 0.30 | 0.54 | |||
| Dietary | ||||
| <8.0 | 75 | 324 | 1.00 | 1.00 |
| 8.0–8.9 | 86 | 369 | 0.99 (0.73–1.36) | 0.96 (0.70–1.31) |
| 9.0–9.9 | 103 | 385 | 1.14 (0.85–1.54) | 1.07 (0.79–1.44) |
| 10.0–10.9 | 81 | 264 | 1.30 (0.95–1.78) | 1.21 (0.88–1.66) |
| ⩾11.0 | 69 | 306 | 0.93 (0.58–1.50) | 0.88 (0.59–1.32) |
| 0.80 | 0.98 | |||
| Total | ||||
| <400 | 87 | 322 | 1.00 | 1.00 |
| 400–699 | 71 | 351 | 0.75 (0.54–1.02) | 0.72 (0.53–0.99) |
| 700–1099 | 78 | 317 | 0.90 (0.66–1.23) | 0.85 (0.63–1.16) |
| 1100–1799 | 95 | 335 | 1.03 (0.77–1.38) | 0.97 (0.72–1.30) |
| ⩾1800 | 83 | 324 | 0.92 (0.68–1.24) | 0.85 (0.63–1.16) |
| 0.80 | 0.52 | |||
| Dietary | ||||
| <300 | 79 | 309 | 1.00 | 1.00 |
| 300–424 | 76 | 332 | 0.90 (0.65–1.24) | 0.88 (0.62–1.26) |
| 425–599 | 95 | 368 | 1.03 (0.76–1.39) | 0.99 (0.73–1.35) |
| 600–849 | 74 | 317 | 0.91 (0.66–1.26) | 0.87 (0.63–1.20) |
| ⩾850 | 90 | 323 | 1.08 (0.75–1.56) | 1.07 (0.74–1.55) |
| 0.96 | 0.99 | |||
| Total5 | ||||
| <2400 | 56 | 320 | 1.00 | 1.00 |
| 2400–3399 | 111 | 358 | 1.75 (1.25–2.40) | 1.67 (1.20–2.30) |
| 3400–4399 | 73 | 320 | 1.24 (0.79–1.93) | 1.17 (0.79–1.73) |
| 4400–5999 | 94 | 331 | 1.54 (1.10–2.16) | 1.44 (1.02–2.02) |
| ⩾6000 | 80 | 320 | 1.33 (0.92–1.93) | 1.22 (0.86–1.74) |
| 0.59 | 0.96 |
Results from NHS and NHS II were pooled to obtain risk estimates for the combined cohorts. All P-values were >0.05 in tests for heterogeneity.
Relative risks were adjusted for age and follow-up cycle. In addition, dietary vitamin C was adjusted for vitamin C supplement use; dietary vitamin E was adjusted for vitamin E supplement use; and dietary retinol was adjusted for multivitamin use and vitamin A supplement use.
Relative risks were adjusted for the covariates listed above plus the following: skin reaction after 2h of sun exposure during childhood, number of sunburns over lifetime (NHS) or during teenage years (NHS II), number of moles on left arm (NHS) or on lower legs (NHS II), hair colour, family history of melanoma, state of residence, menopausal status, oral contraceptive use, postmenopausal hormone use, parity, height, and body mass index.
95% confidence interval.
Total nutrient intakes are from foods plus supplements.
Dietary nutrient intakes are from foods only.
Milligram of α-tocopherol equivalents.
β-carotene analyses for dietary intake were very similar to analyses of total intake because of low use of β-carotene supplements.
Relative risks (RRs) of melanoma by use of vitamin supplements
| Never | 143 | 596 | 1.00 |
| Past | 83 | 302 | 0.96 (0.51–1.83) |
| Current | 185 | 700 | 1.02 (0.82–1.28) |
| Never | 231 | 973 | 1.00 |
| Past | 51 | 209 | 0.97 (0.71–1.32) |
| Current | 129 | 416 | 1.07 (0.64–1.77) |
| Never | 292 | 1189 | 1.00 |
| Past | 40 | 141 | 0.98 (0.70–1.38) |
| Current | 79 | 268 | 1.02 (0.79–1.33) |
P<0.05 in test for heterogeneity of results from NHS and NHS II.
Results from NHS and NHS II were pooled to obtain risk estimates for the combined cohorts.
Relative risks were adjusted for the covariates listed in Table 2 footnote c. In addition, vitamin C supplement use was adjusted for vitamin C from food and vitamin E supplement use was adjusted for vitamin E from food.
95% confidence interval.
Relative risks (RRs) of melanoma by daily servings of fruits and vegetables and by frequency of consumption of orange juice
| <1.0 | 62 | 349 | 1.00 |
| 1.0–1.4 | 58 | 274 | 1.16 (0.80–1.66) |
| 1.5–2.4 | 151 | 524 | 1.42 (0.99–2.04) |
| 2.5–3.4 | 83 | 303 | 1.37 (0.95–1.98) |
| ⩾3.5 | 60 | 198 | 1.37 (0.86–2.20) |
| 0.22 | |||
| <2.0 | 86 | 448 | 1.00 |
| 2.0–2.9 | 126 | 479 | 1.22 (0.92–1.62) |
| 3.0–3.9 | 106 | 356 | 1.32 (0.97–1.78) |
| 4.0–4.9 | 53 | 196 | 1.11 (0.76–1.62) |
| ⩾5.0 | 43 | 169 | 1.01 (0.68–1.50) |
| 0.81 | |||
| <0.25 | 50 | 263 | 1.00 |
| 0.25–0.49 | 116 | 447 | 1.30 (0.51–3.33) |
| 0.50–0.74 | 85 | 347 | 1.18 (0.49–2.85) |
| 0.75–0.99 | 68 | 236 | 1.40 (0.73–2.68) |
| ⩾1.00 | 95 | 355 | 1.24 (0.67–2.29) |
| 0.78 | |||
| <0.5 | 57 | 317 | 1.00 |
| 0.5–0.9 | 77 | 376 | 1.10 (0.77–1.55) |
| 1.0–1.4 | 96 | 378 | 1.33 (0.94–1.87) |
| 1.5–1.9 | 92 | 280 | 1.54 (1.06–2.22) |
| ⩾2.0 | 92 | 297 | 1.43 (0.99–2.07) |
| 0.01 | |||
| Never | 39 | 228 | 1.00 |
| 1–3 month−1 | 70 | 364 | 1.09 (0.73–1.62) |
| 1 week−1 | 44 | 197 | 1.31 (0.83–2.05) |
| 2–6 week−1 | 203 | 799 | 1.44 (1.00–2.08) |
| ⩾1 day−1 | 147 | 499 | 1.61 (0.92–2.84) |
| 0.008 |
P<0.05 in test for heterogeneity of results from the NHS and NHS II.
Results from NHS (1984–1998) and NHS II (1991–1999) were pooled to obtain risk estimates for the combined cohorts.
Relative risks were adjusted for the covariates listed in Table 2 footnote c plus total energy intake, multivitamin use, and use of vitamin C, vitamin E, and β-carotene supplements.
95% confidence interval.
Follow-up for NHS is 1980 – 1998.
Relative risks (RR) of melanoma by daily intakes of dietary vitamin C and total retinol, stratified by risk based on nondietary factors
| <90 | 22 | 167 | 1.00 | 12 | 75 | 1.00 | 19 | 40 | 1.00 | |
| 90–114 | 24 | 158 | 1.15 (0.64–2.07) | 25 | 74 | 2.10 (1.01–4.37) | 16 | 39 | 0.82 (0.41–1.64) | |
| 115–139 | 17 | 163 | 0.78 (0.41–1.49) | 27 | 81 | 2.34 (1.15–4.76) | 21 | 41 | 1.12 (0.60–2.12) | |
| 140–174 | 32 | 179 | 1.29 (0.74–2.25) | 34 | 90 | 2.25 (1.10–4.62) | 37 | 44 | 1.76 (0.99–3.13) | |
| ⩾175 | 29 | 172 | 1.16 (0.65–2.06) | 25 | 85 | 1.55 (0.41–5.82) | 35 | 42 | 1.68 (0.93–3.02) | |
| 0.68 | 0.18 | 0.01 | ||||||||
| <400 | 38 | 162 | 1.00 | 16 | 74 | 1.00 | 19 | 38 | 1.00 | |
| 400–699 | 22 | 186 | 0.51 (0.30–0.86) | 20 | 86 | 0.99 (0.50–1.94) | 26 | 44 | 1.07 (0.58–1.95) | |
| 700–1099 | 24 | 162 | 0.61 (0.28–1.35) | 28 | 79 | 1.47 (0.78–2.77) | 21 | 41 | 0.89 (0.47–1.69) | |
| 1100–1799 | 23 | 168 | 0.50 (0.29–0.85) | 30 | 83 | 1.56 (0.84–2.89) | 33 | 43 | 1.39 (0.78–2.48) | |
| ⩾1800 | 17 | 160 | 0.39 (0.22–0.71) | 29 | 82 | 1.50 (0.81–2.81) | 29 | 40 | 1.36 (0.76–2.44) | |
| 0.01 | 0.16 | 0.46 | ||||||||
Results from NHS (1984–1998) and NHS II (1991–1999) were pooled to obtain risk estimates for the combined cohorts. All P-values were >0.05 in tests for heterogeneity. See text for description of risk score.
Relative risks were adjusted for the covariates listed in Table 2 footnote c.
Person-years of follow-up (thousands).
95% confidence interval.
P-value for interaction between risk score and nutrient intake.